Titlebook: Synbio and Human Health; A Challenge to the C I?igo de Miguel Beriain,Carlos María Romeo Casabon Book 2014 Springer Science+Business Media

Disclose

書目名稱Synbio and Human Health影響因子(影響力)




書目名稱Synbio and Human Health影響因子(影響力)學科排名




書目名稱Synbio and Human Health網(wǎng)絡(luò)公開度




書目名稱Synbio and Human Health網(wǎng)絡(luò)公開度學科排名




書目名稱Synbio and Human Health被引頻次




書目名稱Synbio and Human Health被引頻次學科排名




書目名稱Synbio and Human Health年度引用




書目名稱Synbio and Human Health年度引用學科排名




書目名稱Synbio and Human Health讀者反饋




書目名稱Synbio and Human Health讀者反饋學科排名

蛤肉

https://doi.org/10.1007/978-94-017-9196-0Intellectual property rights; Synthetic biology; open source; patent

HUSH

I?igo de Miguel Beriain,Carlos María Romeo CasabonSynthetic Biology is the most promising, currently existing area of biotechnology specially in human health. However, juridical issues may ruin the development of this market if they are not correctly

Thyroiditis

GULLY

crease

Synthetic Biology and Global Health in the Age of Intellectual Property, of Craig Venter’s model of proprietary science and the ‘open-source’ model of the BioBricks school show that SB is located right at heart of this major contest. The eventual outcome of this legal, political and scientific contest will also be decisive for whether or not developing countries and the

creatine-kinase

美學

Synthetic Biology: Challenges and Legal Questions,ernational debate on the H5N1 virus has shown recently. For example, a Global Health Security Policy Board is under discussion. On the other hand, several national and supranational organizations come to the result that a strict regulation of Synthetic Biology would do more harm than good. Their res

Reservation

Exclusions and Exceptions to Patent Eligibility Revisited: Examining the Political Functions of the“enable access for all”. The latter exception implies a converse logics, namely that preferably no one should access and apply the technological knowledge in question. The second part of the article contends that decisions on whether and how to grant patents in a new technical area also depend on in

Corral

Patentability, Synthetic Biology and Human Genome, its essential characteristics. Subsequently, some considerations will be included on one of its most controversial aspects, which refers to the “moral clause”. Finally, it introduces some considerations on the issue of synthetic biology and its place in the patent legal system.